Mesalamine FDA Link Generic

An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)

Also Known As:

Mesalazine; Canasa; Pentasa; Rowasa; 5 Aminosalicylic Acid; 5-Aminosalicylic Acid; Asacol; Asacolon; Ascolitin; Claversal; Fivasa; Lixacol; Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesasal; Novo-5 ASA; Salofalk; m-Aminosalicylic Acid; meta-Aminosalicylic Acid; 5 Aminosalicylate; Hydrochloride, Mesalamine; Monosodium Salt, Mesalamine; Novo 5 ASA; m Aminosalicylic Acid; meta Aminosalicylic Acid; 5-Aminosalicylate

Pharmalogical Action Categories:

Anti-Inflammatory Agents, Non-Steroidal

Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Benzene Derivatives: 17
        Phenols: 702
        Hydroxybenzoates: 18
        Salicylates: 2354
        Aminosalicylic Acids: 6
        Mesalamine: 2762
        Benzoates: 430
        Hydroxybenzoates: 18
        Salicylates: 2354
        Aminosalicylic Acids: 6
        Mesalamine: 2762
        Aminobenzoates: 1
        meta-Aminobenzoates
        Mesalamine: 2762
- Carboxylic Acids: 986
  - Hydroxy Acids: 97
    - Hydroxybenzoates: 18
      - Salicylates: 2354
        Aminosalicylic Acids: 6
        Mesalamine: 2762
  - Carbocyclic Acids
    - Benzoates: 430
      - Hydroxybenzoates: 18
        Salicylates: 2354
        Aminosalicylic Acids: 6
        Mesalamine: 2762
      - Aminobenzoates: 1
        meta-Aminobenzoates
        Mesalamine: 2762

AJM300 Study Group Selected Research

AJM300 Study Group Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure